The market for endoluminal suturing devices was valued at $73.5 million globally in 2021 and is anticipated to grow at a rate of 11.4% during the forecast period. The prevalence of chronic conditions like obesity and gastrointestinal disorders is on the rise, which is a major reason in the rising market revenue. The International Diabetes Federation (IDF) estimates that 643 million people would...